Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

<i>Leptospira interrogans</i> from Okinawa induces epithelial barrier disruption with different kinetics. حسب Tetsuya Kakita (4922584)

The level of miRNA 221 in the myocardium of MIRI mice was decreased. حسب Hongyu Li (1332669)

الموضوعات:

Personalised preventive approaches by level of prevention, study design and type of disease. حسب Sara Farina (13962753)

الموضوعات:

Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Attitude towards coronary heart disease secondary preventions. حسب Hao Wang (39217)

PGAM5 knockdown prevented rTsSPc from disrupting Caco-2 monolayer integrity. حسب Qi Qi Lu (17721401)

الموضوعات:

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. حسب Luqiong Liu (11537092)

Map of Pakistan with marked Punjab province. حسب Sumaira Sumaira (21453523)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. حسب Luqiong Liu (11537092)

Figure 2 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Figure 4 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Figure 3 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Table S2 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Table S6 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Figure 1 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Table S5 from Clinical Significance of <i>TP53</i>-Mutant Clonal Hematopoiesis Across Diseases حسب Yoshiaki Usui (21631828)

Analysis of factors affecting good practice of coronary heart disease secondary prevention. حسب Hao Wang (39217)